Latest Breaking News On - Hepatocellular carcinoma - Page 4 : comparemela.com

Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR Of 2.82%

Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR Of 2.82%
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

South-africa
United-states
France
Italy
Qatar
Spain
Brazil
Saudi-arabia
Canada
Mexico
Argentina
India

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm

Experts discuss updated findings from key clinical trials in hepatocellular carcinoma presented during the 2024 Gastrointestinal Cancers Symposium.

United-states
Japan
American
Jun-gong
Anthonyb-el-khoueiry
Rachnat-shroff
Michael-morse
European-society-for-medical-oncology-asia-congress
Onclive-peer-exchange
Systemic-therapy
European-society
Medical-oncology-asia-congress

Hypertension Pipeline Outlook Report 2024 (Updated)

Hypertension Pipeline Outlook Report 2024 (Updated)
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Carcinoma-pipeline-insight
Hepatocellular-carcinoma
Key-takeaways

HER2-Negative Breast Cancer Pipeline Outlook Report 2024

HER2-Negative Breast Cancer Pipeline Outlook Report 2024
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Carcinoma-pipeline-insight
Hepatocellular-carcinoma
Key-takeaways

IMBrave150 Study Overview

Dr Gong breaks down the structure and key takeaways from the IMBrave150 study.

Evolving-treatments
Hepatocellular-carcinoma
Imbrave150-study
Atezolizumab-plus-bevacizumab
α-fetoprotein-in-hcc
Immune-mediated-adverse-events
Atezo-bev-in-liver-cirrhosis
Io-based-combination-regimens
Camrelizumab-rivoceranib